Prescription Required
Inclusive of all taxes
In Treatment of Neuropathic pain Avuset PG 200mg/75mg Tablet is used to treat neuropathic or nerve pain. This means it helps in reducing sensations such as burning, throbbing, sharp, numbness, pins and needles pain in arms, hands, fingers, legs, feet, or toes. This helps improve your sleep, mood and reduces tiredness that can be caused by the pain. Along with taking Avuset PG 200mg/75mg Tablet, other treatments like physical therapy, accupuncture, massage or relaxation therapy can help you get relief from neuropathic pain. Consult your doctor who can advise you on this.
It is unsafe to consume alcohol with Avuset PG 200mg/75mg Tablet.
Avuset PG 200mg/75mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Avuset PG 200mg/75mg Tablet during breastfeeding is not available. Please consult your doctor.
Avuset PG 200mg/75mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Avuset PG 200mg/75mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Avuset PG 200mg/75mg Tablet may be needed. Please consult your doctor.
Avuset PG 200mg/75mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Avuset PG 200mg/75mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Avuset PG 200mg/75mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Medley Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Astonea Labs Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Atlantis Formulations Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ipca Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Jenburkt Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Skvamps Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chemo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Tas Med India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Integrace Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Accuminn Labs || ₹14.5/tablet (25% cheaper)